{"schema":"rootz.ai/sec-company/v1","layer":0,"identity":{"name":"Polaryx Therapeutics, Inc.","cik":"0002075320","ticker":"PLYX","exchange":"Nasdaq","sic":"2834","sic_description":"Pharmaceutical Preparations","state_of_incorporation":"WY","headquarters":null,"founded":"2014","ipo_date":null,"status":"active"},"summary":"Polaryx Therapeutics is a clinical-stage biotechnology company developing novel disease-modifying therapies for rare, pediatric lysosomal storage diseases (LSDs). Its pipeline includes PLX-200 (gemfibrozil, oral small molecule), PLX-300 (cinnamic acid), PLX-100 (combination therapy), and PLX-400 (gene therapy). Lead candidate PLX-200 is advancing through a Phase 2 basket trial (SOTERIA) targeting CLN2, CLN3, Krabbe disease, and Sandhoff disease, with an FDA-cleared IND received in October 2025.","peak_metrics":{"market_cap_usd":null,"market_cap_date":null,"employees":null,"employees_date":null,"rd_spend_usd":null,"rd_spend_year":null},"tags":["rare-pediatric-lysosomal-storage-diseases-(lsds)","neuronal-ceroid-lipofuscinoses-(ncls)","krabbe-disease","gm2-gangliosidoses-(tay-sachs-and-sandhoff-diseases)","niemann-pick-disease-types-a-and-b","orphan/rare-disease-therapeutics","505(b)(2)-regulatory-pathway","ppar-dependent-upregulation-of-tfeb","lysosomal-biogenesis-via-tfeb-activation","pi3k-pathway-activation"],"deeper":{"profile":"/api/company/PLYX/profile","timeline":"/api/company/PLYX/timeline","filings":"/api/company/PLYX/filings","people":"/api/company/PLYX/people","skill":"/api/skills/PLYX","skill_json":"/api/skills/PLYX?format=json"},"data_freshness":{"latest_filing":"2026-09-01","latest_extracted":"2026-03-24","latest_quote":"2026-09-04","warning":"New filing(s) detected (2026-09-01) but not yet extracted. Latest extracted data is from 2026-03-24. Extraction runs 3x daily.","stale":true},"origin":{"leaf":"3fd153344f52e84b1309262c9101e2fd6d80b60bf5a5c2a3f0fa15f87bd27e99","parent":"bda9a8b98eb6fac9f6d07c73f67bb278e3ae4b08450e17f8500b04eef4249c4e","timestamp":"2026-09-12T18:41:42.748Z","source":"0001213900-26-033064","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":10,"hourly_limit":500,"remaining":490,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}